Skin testing with bendamustine: what concentration should be used?

We present a case of the patient, who developed hypersensitivity reaction during the treatment of chronic lymphocytic leukemia. Bendamustine was suspected as a culprit agent. The patient as well as 3 controls underwent skin testing with the concentrations of the bendamustine described in earlier stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Malinauskiene, Laura, Cerniauskas, Kestutis, Linauskiene, Kotryna, Griguola, Linas, Chomiciene, Anzelika, Blaziene, Audra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491343/
https://www.ncbi.nlm.nih.gov/pubmed/32944028
http://dx.doi.org/10.1186/s13223-020-00469-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491343/
https://www.ncbi.nlm.nih.gov/pubmed/32944028
http://dx.doi.org/10.1186/s13223-020-00469-3

Ejemplares similares